Does REGADENOSON Cause Infusion site extravasation? 15 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Infusion site extravasation have been filed in association with REGADENOSON (Regadenoson). This represents 0.5% of all adverse event reports for REGADENOSON.
15
Reports of Infusion site extravasation with REGADENOSON
0.5%
of all REGADENOSON reports
0
Deaths
0
Hospitalizations
How Dangerous Is Infusion site extravasation From REGADENOSON?
Of the 15 reports.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGADENOSON. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does REGADENOSON Cause?
Nausea (311)
Dyspnoea (271)
Seizure (247)
Vomiting (233)
Injection site extravasation (226)
Hypotension (200)
Headache (190)
Cardiac arrest (183)
Dizziness (160)
Blood pressure decreased (143)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which REGADENOSON Alternatives Have Lower Infusion site extravasation Risk?
REGADENOSON vs REGORAFENIB
REGADENOSON vs REGORAFENIB\REGORAFENIB
REGADENOSON vs RELATLIMAB
REGADENOSON vs RELPAX
REGADENOSON vs RELUGOLIX